Prota Therapeutics is a developer of new treatment for peanut allergy in children.
Prota Therapeutics has raised $21.0M in total funding. The most recent round was Private Equity. The last funding was announced in January 2024.
Prota Therapeutics's investors include OneVentures, SPRIM Global Investments.
Prota Therapeutics is headquartered in Melbourne, Australia.
Prota Therapeutics is a developer of new treatment for peanut allergy in children.
Prota Therapeutics is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prota Therapeutics — Funding & Investors." VCBacked, January 16, 2024, https://www.vcbacked.co/company/prota-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Prota Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/prota-therapeutics
{{cite web |title=Prota Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/prota-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated